Doubling the diagnostic rate of at-risk metabolic dysfunction-associated steatohepatitis-leave no one behind: author's reply.

Lazarus JV, Alazawi W, Byrne CD, Caussy C, Brennan PN

Open source

DOI
10.1016/j.lanepe.2025.101575
Published
2026 Jan
Container
The Lancet regional health. Europe
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.lanepe.2025.101575,
  title = {Doubling the diagnostic rate of at-risk metabolic dysfunction-associated steatohepatitis-leave no one behind: author's reply.},
  author = {Lazarus JV and Alazawi W and Byrne CD and Caussy C and Brennan PN},
  year = {2026},
  journal = {The Lancet regional health. Europe},
  doi = {10.1016/j.lanepe.2025.101575},
  url = {https://doi.org/10.1016/j.lanepe.2025.101575}
}

RIS

TY  - JOUR
TI  - Doubling the diagnostic rate of at-risk metabolic dysfunction-associated steatohepatitis-leave no one behind: author's reply.
AU  - Lazarus JV
AU  - Alazawi W
AU  - Byrne CD
AU  - Caussy C
AU  - Brennan PN
PY  - 2026
JO  - The Lancet regional health. Europe
DO  - 10.1016/j.lanepe.2025.101575
UR  - https://doi.org/10.1016/j.lanepe.2025.101575
ER  - 

APA

JV, L., W, A., CD, B., C, C., & PN, B. (2026). Doubling the diagnostic rate of at-risk metabolic dysfunction-associated steatohepatitis-leave no one behind: author's reply.. The Lancet regional health. Europe. https://doi.org/10.1016/j.lanepe.2025.101575

Source records